These are the 25 stocks to bet against on a successful COVID-19 vaccine, according to JPMorgan
Drew Angerer/Getty Images
With a successful COVID-19 vaccine on the horizon, some stocks may fare better than others.
According to JPMorgan, investors should look to bet against a handful of stocks that have experienced increased momentum in their business amid the COVID-19 pandemic.
Once a successful COVID vaccine is distributed and administered, it could lead to a slowdown in growth for a number of businesses as a return to normal activity ensues.
Here are 25 stocks traders should bet against once a successful COVID-19 vaccine is disbursed, according to JPMorgan.
Visit Business Insider’s homepage for more stories.
The development of a successful COVID-19 vaccine could have wide-ranging implications on a basket of stocks that saw a surge in growth amid the pandemic.
That’s according to a Friday note from JPMorgan, which put together a list of 25 stocks traders should bet against once a COVID-19 vaccine is distributed and administered to the population.
“This is a list of stocks that are in the upper echelon of Momentum and have crowded positioning, that could see the…
Read full article